Clinical trial

N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure

NCT00248625 · University of Pittsburgh, Other · Completed

Key facts

NCT number NCT00248625
Title N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure
Official title A Multi-center Study of the Safety and Efficacy of N-acetylcysteine in the Treatment of Acute Liver Failure in Pediatric Patients Not Caused by Acetaminophen.
Lead sponsor University of Pittsburgh, Other
Collaborators National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Acute Liver Failure, Hepatic Encephalopathy
Intervention type Drug
Interventions N-acetylcysteine, Placebo
Enrollment 184
Start date Jan 1, 2000
Primary completion Sep 1, 2009
Completion Oct 1, 2010
First posted Nov 4, 2005
Last update posted Jul 28, 2016
Countries Canada, United Kingdom, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies